Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.
暂无分享，去创建一个
F. Kraeber-Bodéré | J. Barbet | D. Loussouarn | J. Wijdenes | A. Faivre-Chauvet | C. Rousseau | M. Chérel | S. Gouard | F. Davodeau | J. Gaschet | K. Bernardeau | A. Ruellan | C. Saï-Maurel